COR Therapeutics, Inc. to Report / Webcast Second Quarter 2001 Financial Results Tuesday, July 17, 2001.Business Editors/Health & Medical Writers SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--July 11, 2001 COR Therapeutics, Inc. (Nasdaq: CORR CORR Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51. ) announced today that it will provide its second quarter 2001 financial results and outlook on Tuesday, July 17, 2001 at 8:00 a.m. Eastern Daylight Time (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ). Two hours later, at 10:00 a.m. EDT, as part of the Company's efforts to ensure full disclosure to all parties, COR will webcast a live conference call via the Company's internet site. The call will be led by Vaughn M. Kailian, President and Chief Executive Officer. The webcast may be accessed by logging onto either http://www.corr.com or http://www.vcall.com/NASApp/VCall/EventPage?ID=75744 on the internet. Please connect to either website at least 10 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the live webcast. In addition, the webcast will be archived and will be available for five business days. COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction ( |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion